Diabetic Retinopathy: Research to Clinical Practice

Overview

Journal Clin Diabetes Endocrinol

Publisher Biomed Central

Specialty Endocrinology

Date 2017 Oct 28

PMID 29075511

Citations 23

Authors

Anjali R Shah

Thomas W Gardner

Affiliations

Soon will be listed here.

Abstract

Background: Diabetic Retinopathy (DR) is a leading cause of visual impairment in the United States. The CDC estimates that the prevalence of DR will triple from 2005 to 2050.

Main Body: The report summarizes major past advances in diabetes research and their impact on clinical practice. Current paradigms and future directions are also discussed.

Conclusions: DR is a leading cause of visual impairment in the US. Significant progress has been made in the understanding and treatment of DR, but rising prevalence demands innovative approaches to management in the future.

Citing Articles

Causal effect of immune cells, metabolites, cathepsins, and vitamin therapy in diabetic retinopathy: a Mendelian randomization and cross-sectional study.

Zhou H, Wang J, Cui X Front Immunol. 2024; 15:1443236.

PMID: 39430744 PMC: 11487118. DOI: 10.3389/fimmu.2024.1443236.

Demographic and Metabolic Risk Factors Associated with Development of Diabetic Macular Edema among Persons with Diabetes Mellitus.

Haliyur R, Marwah S, Mittal S, Stein J, Shah A Ophthalmol Sci. 2024; 4(6):100557.

PMID: 39149711 PMC: 11324816. DOI: 10.1016/j.xops.2024.100557.

Real-World Research on Retinal Diseases Using Health Claims Database: A Narrative Review.

Ahn S Diagnostics (Basel). 2024; 14(14).

PMID: 39061705 PMC: 11276298. DOI: 10.3390/diagnostics14141568.

Non-invasive blood glucose monitoring technology in diabetes management: review.

Chandir Moses J, Adibi S, Wickramasinghe N, Nguyen L, Angelova M, Islam S Mhealth. 2024; 10:9.

PMID: 38323150 PMC: 10839510. DOI: 10.21037/mhealth-23-9.

Glucagon-like peptide-1 receptor agonists and diabetic retinopathy: nationwide cohort and Mendelian randomization studies.

Zheng D, Li N, Hou R, Zhang X, Wu L, Sundquist J BMC Med. 2023; 21(1):40.

PMID: 36737746 PMC: 9898966. DOI: 10.1186/s12916-023-02753-6.

References

Kern T . Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res. 2008; 2007:95103. PMC: 2216058. DOI: 10.1155/2007/95103. View

Federici T . The non-antibiotic properties of tetracyclines: clinical potential in ophthalmic disease. Pharmacol Res. 2011; 64(6):614-23. DOI: 10.1016/j.phrs.2011.06.013. View

Solomon S, Chew E, Duh E, Sobrin L, Sun J, VanderBeek B . Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2017; 40(3):412-418. PMC: 5402875. DOI: 10.2337/dc16-2641. View

Nguyen Q, Brown D, Marcus D, Boyer D, Patel S, Feiner L . Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology. 2012; 119(4):789-801. DOI: 10.1016/j.ophtha.2011.12.039. View

Cohen S, Gardner T . Diabetic Retinopathy and Diabetic Macular Edema. Dev Ophthalmol. 2015; 55:137-46. PMC: 4775164. DOI: 10.1159/000438970. View

Vujosevic S, Micera A, Bini S, Berton M, Esposito G, Midena E . Aqueous Humor Biomarkers of Müller Cell Activation in Diabetic Eyes. Invest Ophthalmol Vis Sci. 2015; 56(6):3913-8. DOI: 10.1167/iovs.15-16554. View

. Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings. Ophthalmology. 1978; 85(1):82-106. DOI: 10.1016/s0161-6420(78)35693-1. View

Carrasco E, Hernandez C, Miralles A, Huguet P, Farres J, Simo R . Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration. Diabetes Care. 2007; 30(11):2902-8. DOI: 10.2337/dc07-0332. View

Keech A, Mitchell P, Summanen P, ODay J, Davis T, Moffitt M . Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet. 2007; 370(9600):1687-97. DOI: 10.1016/S0140-6736(07)61607-9. View

10.

Virgili G, Menchini F, Murro V, Peluso E, Rosa F, Casazza G . Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. Cochrane Database Syst Rev. 2011; (7):CD008081. DOI: 10.1002/14651858.CD008081.pub2. View

11.

Tang J, Kern T . Inflammation in diabetic retinopathy. Prog Retin Eye Res. 2011; 30(5):343-58. PMC: 3433044. DOI: 10.1016/j.preteyeres.2011.05.002. View

12.

Nathan D, Genuth S, Lachin J, Cleary P, Crofford O, Davis M . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14):977-86. DOI: 10.1056/NEJM199309303291401. View

13.

. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol. 1985; 103(12):1796-806. View

14.

Mitka M . Aggressive lipid, hypertension targeting yields no benefit for some with diabetes. JAMA. 2010; 303(17):1681-3. DOI: 10.1001/jama.2010.492. View

15.

Haller J, Kuppermann B, Blumenkranz M, Williams G, Weinberg D, Chou C . Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. Arch Ophthalmol. 2010; 128(3):289-96. DOI: 10.1001/archophthalmol.2010.21. View

16.

Jackson G, Scott I, Quillen D, Walter L, Gardner T . Inner retinal visual dysfunction is a sensitive marker of non-proliferative diabetic retinopathy. Br J Ophthalmol. 2011; 96(5):699-703. DOI: 10.1136/bjophthalmol-2011-300467. View

17.

Haig J, Barbeau M, Ferreira A . Cost-effectiveness of ranibizumab in the treatment of visual impairment due to diabetic macular edema. J Med Econ. 2016; 19(7):663-71. DOI: 10.3111/13696998.2016.1154566. View

18.

Adamis A . Is diabetic retinopathy an inflammatory disease?. Br J Ophthalmol. 2002; 86(4):363-5. PMC: 1771111. DOI: 10.1136/bjo.86.4.363. View

19.

Gardner T, Davila J . The neurovascular unit and the pathophysiologic basis of diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2016; 255(1):1-6. PMC: 5551503. DOI: 10.1007/s00417-016-3548-y. View

20.

Wolfensberger T, Hamilton A . Diabetic retinopathy--an historical review. Semin Ophthalmol. 2004; 16(1):2-7. DOI: 10.1076/soph.16.1.2.4220. View